These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21159144)
1. Fibrate use in diabetes: new concepts. Bloomgarden ZT; Drexler A J Diabetes; 2011 Mar; 3(1):1-2. PubMed ID: 21159144 [No Abstract] [Full Text] [Related]
2. [Fibrates: their prescription must be restricted]. Béliard-Lasserre S Rev Prat; 2015 Dec; 65(10):1243-4. PubMed ID: 26979011 [No Abstract] [Full Text] [Related]
3. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now? Peter R; Reilly E; Anthony S Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346 [No Abstract] [Full Text] [Related]
4. Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations. Hamilton-Craig I; Kostner KM; Woodhouse S; Colquhoun D Int J Evid Based Healthc; 2012 Sep; 10(3):181-90. PubMed ID: 22925614 [TBL] [Abstract][Full Text] [Related]
5. Prevention of cardiovascular disease utilizing fibrates--a pooled meta-analysis. Loomba RS; Arora R Am J Ther; 2010; 17(6):e182-8. PubMed ID: 20535009 [TBL] [Abstract][Full Text] [Related]
6. Use of fibrates in the United States and Canada. Jackevicius CA; Tu JV; Ross JS; Ko DT; Carreon D; Krumholz HM JAMA; 2011 Mar; 305(12):1217-24. PubMed ID: 21427374 [TBL] [Abstract][Full Text] [Related]
7. Fibrate use in the United States and Canada. Tenenbaum A; Fisman EZ JAMA; 2011 Jul; 306(2):157; author reply 158-9. PubMed ID: 21750290 [No Abstract] [Full Text] [Related]
8. Fibrate use in the United States and Canada. Lim LS; Wong TY JAMA; 2011 Jul; 306(2):157-8; author reply 158-9. PubMed ID: 21750289 [No Abstract] [Full Text] [Related]
10. The effects of fibrates on lipoprotein and hemostatic coronary risk factors. Schonfeld G Atherosclerosis; 1994 Dec; 111(2):161-74. PubMed ID: 7718018 [TBL] [Abstract][Full Text] [Related]
11. [Antilipemic therapy in dyslipidemias in obese non-insulin-dependent diabetics (ONIDDM)]. Palel G; Coman A; Petrovanu R; Ungureanu D; Cojocaru M Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):120-2. PubMed ID: 10756782 [TBL] [Abstract][Full Text] [Related]
12. Frequency of creatine kinase elevation during treatment with fluvastatin in combination with fibrates (bezafibrate, fenofibrate, or gemfibrozil). Farnier M; Bortolini M; Salko T; Freudenreich MO; Isaacsohn JL; Troendle AJ; Gonasun L Am J Cardiol; 2003 Jan; 91(2):238-40. PubMed ID: 12521642 [No Abstract] [Full Text] [Related]
13. The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates. Rizzo M; Berneis K Curr Med Res Opin; 2007 May; 23(5):1103-11. PubMed ID: 17519077 [TBL] [Abstract][Full Text] [Related]
14. [Part II. Combination statin plus fibrate regimens (free and fixed)]. Clin Investig Arterioscler; 2016 Jul; 28 Suppl 3():11-9. PubMed ID: 27473466 [No Abstract] [Full Text] [Related]
15. Drugs for hypertriglyceridemia. Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119 [No Abstract] [Full Text] [Related]
16. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent? Broeders N; Knoop C; Antoine M; Tielemans C; Abramowicz D Nephrol Dial Transplant; 2000 Dec; 15(12):1993-9. PubMed ID: 11096145 [TBL] [Abstract][Full Text] [Related]
17. [Part I. Fibrates in primary and secondary prevention]. Clin Investig Arterioscler; 2016 Jul; 28 Suppl 3():3-10. PubMed ID: 27473465 [No Abstract] [Full Text] [Related]